Company American Oriental Bioengineering, Inc. Other OTC
Equities
AOBI
US0287315032
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2011 | Weight | 2012 | Weight | Delta |
---|---|---|---|---|---|
Manufacturing Revenue
67.9
%
| 197 | 92.5 % | 99 | 67.9 % | -49.94% |
Distribution Revenue
32.1
%
| 16 | 7.5 % | 47 | 32.1 % | +192.87% |
Sales per region
USD in Million | 2011 | Weight | 2012 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 213 | 100.0 % | 145 | 100.0 % | -31.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yan Chun Li
FOU | Founder | 55 | - |
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Yan Chun Li
FOU | Founder | 55 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,007 | 58,007 ( 100.00 %) | 0 | 5.483 % |
Stock B | 0 | 1,000,000 | 0 | 0 |
Company contact information
American Oriental Bioengineering, Inc.
1 Liangshuihe First Avenue Beijing E-Town Economic Zone
100176, Beijing
+86 10 5982 2039
http://www.bioaobo.com![address American Oriental Bioengineering, Inc.(AOBI)](https://cdn.zonebourse.com/static/address/16252999.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+62.38% | 841B | |
+39.88% | 625B | |
-4.33% | 360B | |
+18.90% | 327B | |
+10.47% | 300B | |
+15.74% | 242B | |
+18.37% | 227B | |
+14.06% | 174B | |
+0.94% | 162B |